Loading clinical trials...
Loading clinical trials...
An accurate diagnosis of the presence, location and extent of the rectosigmoid endometriosis is of paramount importance for the clinicians in order to inform the patients on the potential surgical or medical treatments. It is well established that transvaginal ultrasonography is the first-line investigation in patients with suspicion of deep infiltrating endometriosis. An improvement in the performance of transvaginal ultrasonography in diagnosing rectosigmoid endometriosis may be obtained by using rectal water contrast during transvaginal ultrasonographic scan.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
IRCCS Ospedale Policlinico San Martino
Genoa, Italy
Start Date
January 1, 2018
Primary Completion Date
January 1, 2021
Completion Date
March 1, 2022
Last Updated
March 30, 2021
240
ACTUAL participants
Three-dimensional rectal water contrast transvaginal ultrasonography (3D-RWC-TVS)
DIAGNOSTIC_TEST
Two-dimensional rectal water contrast transvaginal ultrasonography (2D-RWC-TVS)
DIAGNOSTIC_TEST
Lead Sponsor
Ospedale Policlinico San Martino
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions